Skip to content
Lower risk Medical device recall · FDA · Published July 24, 2017

Zimmer NexGen LPS Femoral Component Recall: Packaging Foam Risk

Zimmer recalls NexGen LPS Femoral Component (Size G) due to potential packaging foam breach during shipping. Affected items have specific lot numbers. Consumers should contact Zimmer for details.

🇺🇸 FDA recall #Z-0663-2018Medical deviceZimmer ›
Take action

Contact the company

Recalling firmZIMMER ORTHOPEDIC MFG LTDBuilding No 2 East Park, Shannon Industrial Estate · Shannon, Ireland
✎ GovInfoNow plain-language explainer

What happened, in plain English

Zimmer is recalling NexGen LPS Femoral Components (Size G) for left and right knees. The recall is due to a risk that the packaging foam might be too small, potentially causing damage during shipping. This could affect the implant's integrity in knee replacements. Read more at govinfonow.com/recall/73370-zimmer-nexgen-lps-femoral-component-recall-packaging-foam-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/73370-zimmer-nexgen-lps-femoral-component-recall-packaging-foam-risk · Updated September 20, 2026 · FDA enforcement record: FDA #Z-0663-2018

Cite this page

“Zimmer NexGen LPS Femoral Component Recall: Packaging Foam Risk.” GovInfoNow, updated September 20, 2026. https://govinfonow.com/recall/73370-zimmer-nexgen-lps-femoral-component-recall-packaging-foam-risk. Based on FDA recall #Z-0663-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0663-2018%22&limit=1).

Why it’s dangerous

The packaging foam used during shipping might be undersized, which could lead to a breach in the inner cavity when the product is transported. This breach might compromise the implant's structural integrity during installation.

Who’s affected

Patients who received a NexGen LPS Femoral Component (Size G) for knee replacement surgery are likely affected. Surgeons and medical facilities using these components during procedures are at risk.

How to tell if you have this one

Check for the item number 00-5964-017-51 and lot numbers 63329529, 63342472, 63329533, or 63329527 on the packaging or documentation. These components are used in total knee replacements.

  • Brand
    Zimmer
  • Product
    NexGen LPS Femoral Component, Left and Right, Size G Replaces the femoral condyle of the knee joint in Total Knee
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Contact Zimmer

    Reach out to Zimmer Orthopedic Manufacturing Ltd. for specific instructions on how to handle the recalled components.

Where it went and when

Where it was distributed

Distributed in 6 states, and outside the U.S.

Alaska: not listedAKMaine: yesMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: yesMNIllinois: not listedILWisconsin: yesWIMichigan: yesMINew York: not listedNYRhode Island: not listedRIMassachusetts: yesMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: yesCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Worldwide Distribution - US Distribution to the states of : CA, MA, ME, MI, MN and WI., and to the countries of Germany, France and Italy.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: California, Maine, Massachusetts, Michigan, Minnesota, Wisconsin.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Jul 24, 201712. FDA classified it Class II: Feb 21, 201823. Published in FDA’s Enforcement Report: Feb 28, 201834. FDA terminated the recall: Apr 16, 2018420172018
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Are there any safety risks to patients using this product?

The recall indicates a potential risk during shipping, but there are no reported injuries or immediate safety concerns for patients in normal use.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0663-2018 (July 24, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0663-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on September 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA